Evaluation of the screening for an uterine transplantatio

Recruiting

• Conditions: N97.2; Female infertility of uterine origin

• Registration Number: DRKS00015135
• Lead Sponsor: Forschungsinstitut für FrauengesundheitDepartment für Frauengesundheit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-07-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

AUFI:
- Age: 18 - 37 years
- Patients with AUFI
- written consent
Donor:
- Age: 18 - 64 years
- written consent

Exclusion Criteria

- BMI> 30kg / m2
- Pre-existing malignancies in the last 5 years
- missing consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The purpose of this study is to evaluate the screening of AUFI patients and live donors, which will be screened for UTx at the Department of Women's Health, in order to develop robust criteria for the suitability for UTx. All data relevant to the study (age, BMI, blood group, pre-existing conditions, psychological assessment, etc.) are requested as part of the clinical routine. No study-specific examinations are carried out.

Secondary Outcome Measures

Name	Time	Method
ong-term effects and outcomes of UTx to obtain a comprehensive assessment of the effectiveness and impacts of the transplantation.